Related Experiment Video
Updated: Apr 15, 2026

Investigating the Alleviating Effects of Bacillus cereus Administration on Colitis through Gut Microbiota Modulation
Published on: July 27, 2022
Ophiopogon japonicus Polysaccharides Promote Microbial Production Of Chenodeoxycholic Acid To Alleviate Ulcerative
Xin Gao1, Cui Zhang1,2, Zeman Zhao1,2
1State Key Laboratory of Magnetic Resonance and Imaging, National Centre for Magnetic Resonance in Wuhan, Innovation Academy of Precision Measurement Science and Technology, Chinese Academy of Sciences (CAS), Wuhan 430071, China.
Abstract:
Ophiopogon japonicuspolysaccharides (OJP) commonly used as functional food additives have been known to have various pharmacological activities. However, the exact roles of OJP in treating ulcerative colitis (UC) remain unknown. Here, we found that oral administration of OJP at different dosages effectively alleviated colonic injury and restored intestinal homeostasis in UC mice in a gut microbiota-dependent manner. Notably, the OJP treatment markedly improved the gut dysbiosis by enriching probiotics, especiallyLactobacillus salivarius, and triggering the production of chenodeoxycholic acid (CDCA), a primary bile acid with controversial biological function. Supplementation with both CDCA andL. salivariuscan significantly repair gut barrier dysfunction and alleviate intestinal inflammation in DSS-induced UC mice. Mechanistically, CDCA treatment strikingly inhibited the STING1-related NF-κB pathway in UC mice probably by binding to STING1, thus strongly suppressing colonic inflammatory status. These results suggest that OJP has potential preventive or therapeutic effects for inflammatory diseases.
More Related Videos
06:24Author Spotlight: Liujunzi Decoction as a Traditional Chinese Treatment for Coloproctitis Cancer
Published on: October 13, 2023
08:58Analyzing Beneficial Effects of Nutritional Supplements on Intestinal Epithelial Barrier Functions During Experimental Colitis
Published on: January 5, 2017
Related Concept Videos
Inflammatory Bowel Disease IV: Pharmacological Management
Pharmacologic...
Drugs for Treatment of Ulcerative Colitis in IBD
Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
Peptic Ulcer Disease II: Pathophysiology
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
Drugs Affecting GI Tract Motility: Opioids as Antidiarrheal Agents
Opioids, widely used antidiarrheal agents, mitigate diarrhea by slowing down...
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...